KRT80 and cancer: According to Kaplan–Meier plotter, KRT80 mRNA expression was negatively correlated with a long overall survival time of the cancer patients with stage 2, low mutation burden, decreased mesenchymal stem and natural killer cells (Supplementary Figure S1, p < .05), but the converse results were seen in those patients with stage 3 and high mutation burden (Supplementary Figure S1, p < .05).